Details for 2018708025
Up to date per 03.04.2026
Actions
Details for 2018708025
Granted/Registered
European Patent
25.12.2019 A
05.10.2022 B1
17.02.2017
US
201762460692 P
10.08.2017
US
201762543658 P
08.11.2017
US
201762583314 P
C07K 14/79 20060101AFI20210609BHEP
Owner
Denali Therapeutics Inc.161 Oyster Point Boulevard South San Francisco, California 94080US
Representative
No representatives present
Inventor
CHEN, Xiaochengc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco California 94080US
DENNIS, Mark S.c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco California 94080US
KARIOLIS, Mihalisc/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco California 94080US
SILVERMAN, Adam P.c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco California 94080US
SRIVASTAVA, Ankitac/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco California 94080US
WATTS, Ryan J.c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco California 94080US
WELLS, Robert C.c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco California 94080US
ZUCHERO, Joy Yuc/o Denali Therapeutics Inc. 161 OysterPoint Blvd. South San Francisco California 94080US
Information about Fees